Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank86
3Y CAGR-17.7%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-17.7%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 57.15% |
| 2024 | 113.00% |
| 2023 | -4137.05% |
| 2022 | 102.62% |
| 2021 | -58.32% |
| 2020 | -0.66% |
| 2019 | -83.59% |
| 2018 | -39.40% |
| 2017 | -27.24% |
| 2016 | -14.79% |